Screener
Nektar Therapeutics NKTR Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Nektar Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026. Open the filing →
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
FAQ
- What is Nektar Therapeutics's operating margin?
- Nektar Therapeutics (NKTR) reported operating margin of -242% in Q1 2026.
- What is the long-term trend for Nektar Therapeutics's operating margin?
- Over 4 years (2020 to 2025), Nektar Therapeutics's operating margin has grown at a -2.3% compound annual growth rate (CAGR), from -278% to -253.7%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Nektar Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude